Infectious Risk with B Cell Therapies in Lupus A UK registry study of moderate to severe SLE showed that treatment with rituximab or belimumab was not associated with a greater risk of serious infection, when compared to standard of care therapy. https://t.co/Dko5UQAl0G https://t.co/DQcrWtzQuY